Sorai
Decision-Grade Review
Market Trends
Feb 14, 2026 · 15 min read · Sorai Editorial · M&A Diligence Research · Updated Mar 30, 2026
AI adoption in M&A is moving from experimentation to workflow integration. This guide explains what leaders do differently, where laggards stall, and what the data actually supports.
Quick answer
AI adoption in M&A is no longer mainly about curiosity. It is increasingly about workflow design, execution discipline, and the ability to convert large volumes of deal information into faster, better-supported decisions. Deloitte reported in 2025 that 86% of surveyed organizations had integrated GenAI into M&A workflows, while McKinsey reported meaningful cost and cycle-time improvements among users. The important gap is no longer who has tried AI once, but who has operationalized it in a way that changes real deal work.
AI adoption in M&A is often discussed as if the key question were simply how many firms use it. That is too shallow. The harder and more useful question is which firms are turning AI into real operating capability and which firms are still treating it as an experiment that sits outside the core deal workflow.
That distinction matters because the competitive gap does not open when one firm buys software and another does not. It opens when one firm changes how it screens targets, reviews documents, escalates issues, and supports decision-making, while another firm continues to rely on slower and more fragmented workflows.
Deloitte's 2025 M&A generative AI study makes clear how broad the experimentation and integration base has already become: 86% of surveyed organizations reported having incorporated GenAI into M&A workflows in some form [Deloitte, "2025 GenAI in M&A Study," 2025]. McKinsey's January 2026 work pushes the conversation one step further by reporting that respondents using gen AI in M&A saw roughly 20% lower costs on average, while 40% reported deal cycles that were 30% to 50% faster [McKinsey & Company, "Gen AI in M&A: From theory to practice to high performance," January 2026]. Bain's 2024 and 2025 M&A reports reinforce the same broad direction: the market is moving beyond casual interest toward practical evaluation of where AI helps most inside dealmaking [Bain & Company, "2024 M&A Report," 2024]; [Bain & Company, "2025 Global M&A Report," 2025].
The word adoption is misleading because it covers very different states of maturity.
At the lowest level, a team may simply test a general-purpose AI tool to summarize notes or compare a few documents. That counts as exposure, but it does not change how deals get done.
At a higher level, a team may run pilots inside specific workflows such as target screening, document review, or issue triage. This is more meaningful, but still does not guarantee durable change.
Real adoption begins when AI becomes part of the repeatable operating record. That means the tool is used in live workflows, the outputs are tied to evidence, ownership is clear, the team measures results, and the process keeps working across multiple deals rather than only in a demo or a one-off pilot.
This is why the leaders-versus-laggards distinction matters more than the raw adoption rate. Plenty of firms can say they use AI. Fewer can show that it has changed throughput, cost, and decision quality in a defensible way.
The firms pulling ahead are usually not the ones making the boldest claims. They are the ones making the most disciplined workflow choices.
Leaders usually do not begin with an abstract mandate to "use AI across M&A." They start with one place where the current process is slow, repetitive, and evidence-heavy. That often means target screening, market mapping, document review, issue synthesis, or integration planning.
These are good first use cases because the workflow is measurable and the pain is already clear. If a team can reduce document review drag or improve the quality of first-pass screening, the value is easier to observe than in more speculative use cases.
This is the most important operational distinction. Leaders use AI to speed research and synthesis, but they do not let the evidence disappear into unsupported summaries. Outputs remain tied to the contracts, filings, notes, and workpapers that produced them.
That is what makes AI usable in real deal settings. Without that evidence traceability, the tool may look fast but it creates review risk instead of removing it.
Someone owns the workflow, someone owns the validation standard, and someone owns the measurement. Laggards often fail here. A tool is bought, a few people experiment, and no one owns the process long enough to turn experimentation into operating practice.
Leaders do not ask whether people liked the demo. They ask whether the team screened better targets, escalated issues earlier, reduced time spent on repetitive review, or improved the clarity of investment committee materials.
This is where McKinsey's 2026 findings are most useful. The reported cost and cycle-time gains matter not because they make a good headline, but because they imply that some firms have already moved beyond experimentation into measurable operating change [McKinsey & Company, "Gen AI in M&A: From theory to practice to high performance," January 2026].
Most lagging firms are not blocked by lack of awareness. They are blocked by weak operating choices.
The firm starts by asking which tool to buy instead of which workflow needs redesign. That often leads to shallow experimentation with no durable process change.
When teams try to cover sourcing, diligence, modeling, integration, and reporting at the same time, they usually spread attention too thin and fail to operationalize any one workflow well.
If the team does not know how an AI-assisted output should be checked, by whom, and against what evidence, adoption stalls because reviewers lose trust in the results.
Deloitte's 2025 study is especially relevant here because it highlights how central data security and governance remain in M&A AI adoption [Deloitte, "2025 GenAI in M&A Study," 2025]. Firms that treat security, confidentiality, and reviewability as afterthoughts tend to slow themselves down later when legal, compliance, or deal leaders refuse to rely on the tool in real situations.
A common laggard pattern is to use AI in one isolated stage without preserving the context for the next. The team might get a faster summary at the top of the funnel, but then has to rebuild everything manually when the opportunity moves into deeper review.
The most durable first use cases in M&A are usually the ones with four characteristics: high information volume, high repetition, high comparison burden, and clear human review points.
Map the process
Sorai is built for teams that need financial, tax, and legal diligence to stay aligned before the final memo sprint.
McKinsey's M&A work highlights target identification and sourcing as strong opportunities for GenAI because these stages involve large amounts of research, categorization, and synthesis [McKinsey & Company, "Gen AI in M&A: From theory to practice to high performance," January 2026]. Firms benefit when they can define the target universe more intelligently and keep it current without overwhelming the deal team with noise.
This is a natural fit because the work is evidence-heavy and repetitive, and the payoff from faster organization and issue escalation is tangible.
One of the biggest sources of M&A friction is the translation layer between financial, legal, tax, and commercial findings. AI can help when it reduces that translation burden without obscuring the underlying source material.
Bain's broader 2024 and 2025 framing around selectivity and execution discipline matters here because adoption only becomes strategic when it improves follow-through, not just analysis [Bain & Company, "2024 M&A Report," 2024]; [Bain & Company, "2025 Global M&A Report," 2025].
The leaders-versus-laggards gap tends to widen because adoption creates compounding process improvements.
Once AI is tied to actual workflows, the firm begins to accumulate structured knowledge about what worked, what did not, and where delays or false positives appeared.
Because the workflow is measurable, they can refine prompts, data inputs, issue taxonomies, and validation steps over time. That makes the process better on the next deal, not only the current one.
When a firm does not operationalize AI, it continues to absorb the full burden of manual screening, fragmented review, and repeated synthesis. That does not always create immediate failure. It does create a steadily widening execution disadvantage.
Once some teams demonstrate that a workflow can be faster and more evidence-linked, the rest of the organization recalibrates what "normal" looks like. Firms that do not create that internal benchmark often underestimate how much they are still losing to process friction.
The most pragmatic path is usually narrow, measured, and cumulative.
Choose a use case where the team already knows the pain. That could be target screening, document review, or issue synthesis.
Who checks the output? What evidence must be visible? What counts as a usable result? These rules should exist before adoption scales.
Track review time, issue quality, false positives, cycle-time reduction, or other process metrics that matter to the team.
This is where many programs fail. They expand after a promising demo instead of after a stable operating change.
Speed gains are only durable if security, confidentiality, and auditability stay in the design. Otherwise the firm eventually slows itself down again through mistrust and rework.
The current evidence does support the conclusion that AI use in M&A is broadening, that workflow integration is increasing, and that firms using gen AI in M&A are seeing measurable benefits in cost and cycle time [Deloitte, "2025 GenAI in M&A Study," 2025]; [McKinsey & Company, "Gen AI in M&A: From theory to practice to high performance," January 2026].
What the evidence does not support is lazy overstatement. Not every tool works. Not every firm is mature. Not every use case is proven equally well. The market is moving quickly, but the advantage belongs to firms that treat adoption as an operating discipline rather than a branding exercise.
Sorai is built for the workflows where adoption becomes meaningful: evidence-heavy, multi-workstream deal processes that need more continuity between raw data, issue ownership, and senior review. In that context, AI is most valuable when it reduces translation friction and preserves context rather than simply generating faster summaries.
AI adoption in M&A is no longer mainly a story about who has access to the tools. It is a story about who has redesigned enough of the workflow to benefit from them. Leaders operationalize narrow high-friction use cases, preserve the evidence trail, and measure real process outcomes. Laggards experiment without turning those experiments into dependable execution capability.
Sources cited
Author
Editorial review team for Sorai's public diligence content
The editorial team translates public primary-source research and Sorai's workflow perspective into material designed for private equity, corporate development, and transaction advisory readers.
Frequently asked questions
Real adoption means AI is embedded in repeatable deal workflows such as screening, document-heavy diligence, issue synthesis, or integration planning. It does not simply mean a team has tested a chatbot or purchased a pilot tool.
Usage is rising quickly, but maturity still varies widely. Deloitte reported in 2025 that 86% of surveyed organizations had integrated GenAI into M&A workflows in some form, which suggests broad activity. The more important distinction is whether that activity changes execution meaningfully or remains limited to isolated experiments.
McKinsey reported in early 2026 that respondents using gen AI in M&A saw roughly 20% lower costs on average, and 40% reported deal cycles that were 30% to 50% faster. Those numbers are meaningful, but they apply to firms that have embedded AI into workflows rather than simply turned tools on.
The earliest practical use cases are usually the most research-heavy and document-heavy ones: target screening, market mapping, document review, synthesis, and issue escalation. These are the areas where AI can reduce repetitive analysis without displacing the judgment layer.
Because adoption is not mainly a software problem. Laggards usually lack clear workflow ownership, measurable use cases, governance around evidence and security, or the operating discipline needed to turn pilots into routine practice.
Go deeper
Use the service pages below to review how Sorai supports pre-LOI screening, full diligence, and review-readiness across the deal cycle.
Relevant workflow
Review the early-confidence workflow for screening before full diligence cost is committed.
Relevant workflow
See the shared operating record that connects evidence, owners, and review decisions.
Relevant workflow
Understand how Sorai supports the financial workstream once the deal moves into full verification.
Related reading
AI Due Diligence
AI changes M&A due diligence by accelerating document ingestion, extraction, issue triage, and synthesis. Here is how serious deal teams use it without losing review quality or control.
Private Equity
PE deal sourcing works when firms combine a clear investment thesis, disciplined proprietary outreach, and systematic screening that keeps the pipeline active between live processes.
AI Strategy
The future of deal intelligence is not fully autonomous M&A. It is a more connected operating model where AI handles more synthesis, monitoring, and workflow coordination while humans retain judgment.